TG Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
40,485.50
78,775.80
77,227.80
44,885.10
84,716.70
68,806
Total Accounts Receivable
27.20
85.50
186.00
83.90
108.50
95
Other Current Assets
1,790.60
6,353.70
9,459.50
5,895.20
8,492.30
10,130
Total Current Assets
42,303.30
85,215.00
86,873.30
50,864.10
93,317.40
79,031
Net Property, Plant & Equipment
5.70
20.40
47.10
328.10
248.00
251
Total Investments and Advances
4,918.90
-
25,582.20
583.20
587.30
1,241
Long-Term Note Receivable
-
575.00
-
-
-
-
Intangible Assets
799.40
799.40
799.40
799.40
799.40
799
Other Assets
85.10
137.10
171.20
2,206.70
2,429.40
2,294
Total Assets
48,112.40
86,746.90
113,473.20
54,781.50
97,381.50
83,616
ST Debt & Current Portion LT Debt
677.80
275.20
211.50
68.90
127.60
Accounts Payable
4,764.50
3,991.60
9,346.10
15,267.70
25,877.20
Other Current Liabilities
874.90
854.40
970.90
1,541.90
1,952.40
Total Current Liabilities
6,317.20
5,121.20
10,528.50
16,878.40
27,957.20
Long-Term Debt
64.50
-
-
-
-
Other Liabilities
1,676.20
1,523.80
1,371.40
2,035.30
2,431.30
Total Liabilities
8,057.90
6,645.00
11,899.90
18,913.70
30,388.50
Common Equity (Total)
40,054.50
80,101.90
101,573.30
35,867.80
66,993.10
Total Shareholders' Equity
40,054.50
80,101.90
101,573.30
35,867.80
66,993.10
Total Equity
40,054.50
80,101.90
101,573.30
35,867.80
66,993.10
Liabilities & Shareholders' Equity
48,112.40
86,746.90
113,473.20
54,781.50
97,381.50
About TG Therapeutics
View Profile
